A detailed history of Gyroscope Capital Management Group, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Gyroscope Capital Management Group, LLC holds 600 shares of VRTX stock, worth $301,470. This represents 0.05% of its overall portfolio holdings.

Number of Shares
600
Holding current value
$301,470
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $202,908 - $217,476
600 New
600 $208,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Gyroscope Capital Management Group, LLC Portfolio

Follow Gyroscope Capital Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyroscope Capital Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gyroscope Capital Management Group, LLC with notifications on news.